Company Presentation
Phialogics AG
| Country: | Suisse |
| Category: | Emerging Biotech Company |
| Room: | Singapore |
| Date: | April 23, 2024 |
| Time: | 14:45 – 15:00 |
| Website: | www.phialogics.com |
| Speaker: | Andreas Ernst, CEO / CSO |
Company profile
Phialogics is a preclinical biotech company specialized in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation.
Phialogics concept is based on the targeted modification of immunoglobulin receptor domains (IgVs) to modulate immune response in inflammatory diseases.
